Evidence map›Paper›PMID 31805100›Full record

ArticlePloS one2019

Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?

Uiara Regina Silva de Lima, Luciano Vanolli, Elizabeth Coelho Moraes, Jorim Severino Ithamar, Conceição de Maria Pedrozo E Silva de Azevedo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Uiara Regina Silva de LimaPost-graduation Program of Health Science, Federal University of Maranhão, São Luís, MA, Brazil.
Luciano VanolliMedicine Graduate Program, Federal University of Maranhão, São Luís, MA, Brazil.
Elizabeth Coelho MoraesMedicine Graduate Program, Federal University of Maranhão, São Luís, MA, Brazil.
Jorim Severino IthamarPresident Vargas Hospital, São Luís, MA, Brazil.
Conceição de Maria Pedrozo E Silva de AzevedoPost-graduation Program of Health Science, Federal University of Maranhão, São Luís, MA, Brazil.ORCID 0000-0003-0712-1852
Universidade Federal do Maranhão · BRFundação Getulio Vargas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to compare cases of Visceral Leishmaniasis (VL) with and without HIV in a state in northeastern Brazil. METHODOLOGY: We performed a comparative study in the state's referral hospital for infectious/parasitic diseases located in Northeast Brazil between January 2007 and July 2017. The data obtained using this protocol were analyzed with SPSS. PRINCIPAL

findingsIn total, 252 patients were evaluated, including 126 with coincident VL/HIV and 126 with VL alone. Both groups primarily consisted of male patients. The most commonly affected ages were 30-39 years in the coinfected group and 19-29 years in the VL group (p < 0.001). Fever and anorexia (p = 0.001), which were more common in those with VL alone, were frequently observed, while diarrhea, vomiting, bleeding and dyspnea were more common in patients with VL/HIV coinfection (p<0.005). According to the hemogram results, leukocyte levels were lower in the VL group (p < 0.0001). Additionally, AST (aspartate aminotransferase) and ALT (alanine aminotransferase) levels differed between the groups, with higher levels in patients with VL (p < 0.001). On average, HIV was diagnosed 2.6 years before VL (p < 0.001), and VL relapse was observed only in the coinfection group (36.5% of cases). Fever (β = +0.17; p = 0.032) in the first VL/HIV episode was identified as a risk factor for relapse (R2 = 0.18). More deaths occurred in the VL/HIV group (11.1%) than in the VL group (2.4%). CONCLUSION/SIGNIFICANCE: VL/HIV was found to be prevalent among young adults, although the median patient age was higher in the VL/HIV group. The classic symptomatology of VL was more common in patients not coinfected with HIV; therefore, attention is needed in patients with HIV who present with any symptoms that suggest the presence of VL, especially in endemic areas. No cases of VL relapse occurred in patients without HIV, and death was more common in the VL/HIV co-infected group.

Indexed as

AdultAgedBiomarkersBrazilCoinfectionFemaleHIV InfectionsHumansLeishmania donovaniLeishmaniasis, VisceralMaleMiddle AgedPopulation SurveillancePrevalenceRisk FactorsSerologic TestsBiomarkers

Identifiers

PMID31805100
PMCPMC6894860
OpenAlexW2994028422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.